Page 34 - BSAVA Guide to Pain Management in Small Animal Practice

4 | Chronic and osteoarthritic pain

VetBooks.ir examination, further diagnostic imaging and Treatment of chronic pain
Based on the history and clinical
Chronic pain has many di erent aetiologies and
haematological biochemical evaluation may be
necessary. If the aetiology is identi able, a these should be considered when devising a
resolution may be possible, but in many cases treatment plan. he goal of treatment is the
long-term palliative treatments will be required. provision of e ective analgesia with minimal
he use of a uestionnaire at each visit will help side e ects. any di erent analgesics can be
to tailor the treatment plan and assess used and the agents are listed in igures 4.
improvement or deterioration. dogs and 4.4 cats , with suggested algorithms
for approaches to treatment outlined in igures
4. dogs and 4.6 cats .

Dose Comments
Carprofen mg kg orally h or divided in two Indicated for musculoskeletal disorders
doses for days, then reduced to mg kg and DJD
daily depending on clinical response
Cimicoxib mg kg orally h Indicated for pain and in ammation of A
eracoxib mg kg orally h Indicated for OA in USA
No MA in UK
Etodolac mg kg orally h Indicated for OA in USA
No MA in UK
irocoxib mg kg orally h Indicated for OA in dogs
ield trials limited to 9 days
Grapiprant mg kg orally h Indicated for OA
Paracetamol mg kg orally h
acetaminophen mg kg i.v. h
Phenylbutazone mg kg orally h preferably divided in Indicated for OA, rheumatoid and other
two or three doses for days, then mg arthritic diseases
kg h divided in two or three doses
Prednoleucotropin mg kg cinchophen and . mg kg Indicated for OA, 14 day trial followed by
PL prednisolone orally q12h 14 days free of treatment
(cincophen and
prednisolone
avacoxib mg kg orally once then repeated days Indicated for pain and in ammation of
later, then monthly for up to 6 months
eloxicam . mg kg orally h on day , followed by Indicated for pain and in ammation in
. mg kg orally chronic musculoskeletal disorders
Robenacoxib mg kg orally h Indicated for pain and in ammation of
chronic OA
epoxalin mg kg orally h on day followed Indicated for OA
by mg kg orally h
Non steroidal anti in ammatory drugs NSAI s and other anti in ammatory and pain relieving products
3 for use in dogs with chronic maladaptive pain. Very few products have long term market authori ation
A and treatment must be closely supervised by a veterinary surgeon. Consult datasheets for further information.
Use the lowest e ective dose and a multimodal approach. All NSAI s are capable of causing gastrointestinal signs
and lesions, and hepatic and renal in ury. Regular monitoring of patients is necessary. degenerative oint
disease; A osteoarthritis.

29

Ch04 Pain Management.indd 29 19/12/2018 10:35